Home > Healthcare > Medical Devices > Diagnostic Devices > point of care glucose testing market
Get a free sample of Point-of-Care Glucose Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Point-of-Care Glucose Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Recent advancements in point-of-care (POC) glucose testing have significantly enhanced the accuracy, convenience, and overall management of diabetes. Innovations, ranging from integration with continuous glucose monitoring systems to the development of advanced sensor technologies, are transforming how glucose levels are monitored and managed.
The point-of-care glucose testing market was valued at USD 3.4 billion in 2023 and will witness a 4.7% CAGR between 2024 and 2032 driven by the rising incidence of diabetes.
The test strips segment in the point-of-care glucose testing industry will attain USD 2.3 billion by 2032, due to their high accuracy and precision in glucose measurement.
U.S. point-of-care glucose testing market is expected to surpass USD 1.9 billion by 2032, owing to the highest diabetes prevalence rates, along with a well-established healthcare infrastructure that supports the widespread use of advanced medical technologies.
Abbott Laboratories, ARKRAY, Inc., ACON Laboratories, Inc., B. Braun Melsungen AG, and Dexcom, Inc., among others.